| lncRNA name in article | Virus & Strain Name | Dosage & Time point | Cell line | Experiment Type | Fold change | Expression | P-value | Differential expression quantification method | Statistical method | Year | PubMed ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| C6orf155 | Enterovirus 71 (GDFS-3 strain of EV 71) | 10^2 TCID50/mL ;
24 hr |
RD Human embryonal rhabdomyosarcoma cells | Microarray | 5.3847976 | Upregulation | p < 0.05 | GeneSpring GX v12.0 software package (Agilent Technologies) | Not provided | 2013 | 23220233 |
| LINC00472 | Zika virus (MR766 strain of ZIKV (African lineage)) | MOI < 0.1 ;
56 hr |
Human neural progenitor cells (hPCs) | RNA-Seq | 0.476001174 | Downregulation | p ≤ 0.05 | Cuffdiff | two Sample t-test | 2017 | 29116029 |
| LINC00472 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 2 ;
24 hr |
A-549 Human adenocarcinomic alveolar basal epithelial cells | RNA-Seq | 0.486921126 | Downregulation | 2.15E-05 | student's t test | 2020 | 32416070 | |
| LINC00472 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 0.2 ;
24 hr |
A-549 Human adenocarcinomic alveolar basal epithelial cells (ACE2+) | RNA-Seq | 4.756136102 | Upregulation | 3.59E-27 | student's t test | 2020 | 32416070 | |
| LINC00472 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 2 ;
24 hr |
A-549 Human adenocarcinomic alveolar basal epithelial cells (ACE2+) | RNA-Seq | 5.642575248 | Upregulation | 3.30E-25 | student's t test | 2020 | 32416070 |
* MOI :Multiplicity of infection , TCID :Tissue Culture Infectious Dose